Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating cebranopadol for acute postoperative pain after bunionectomy, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cebranopadol (cebranopadol)

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Acute Pain | Phase 3 | Status: COMPLETED